European Research Ranking Latest Projects www.researchranking.org 2026-08-30T13:24:27+02:00 ERR feed generator 196375 Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine Coordinator: GLAXOSMITHKLINE BIOLOGICALS, Rixensart, BE<br>Funding: 15153216.00<br>Start Date: 2014-10-07<br>End Date: 2017-10-07 2015-05-09T00:00:00+02:00 2015-05-09T00:00:00+02:00 50.7153 4.53326 110445 "Proposal to assess an innovative Immunotherapy, based on a thioredox peptide antigen, in a Phase I Trial for Type-1 Diabetes" Coordinator: GLAXOSMITHKLINE BIOLOGICALS, Rixensart, BE<br>Funding: 6000000.00<br>Start Date: 2014-02-01<br>End Date: 2019-01-31 2013-11-09T00:00:00+01:00 2013-11-09T00:00:00+01:00 50.7153 4.53326 109436 Exploring the roles and plasticity of T-cell responses in anti-BACterial immunity Coordinator: GLAXOSMITHKLINE BIOLOGICALS, Rixensart, BE<br>Funding: 169800.00<br>Start Date: 2013-05-01<br>End Date: 2015-04-30 2013-07-27T00:00:00+02:00 2013-07-27T00:00:00+02:00 50.7153 4.53326 109115 Understanding how immunostimulant combinations in adjuvants synergise to enhance vaccine responses Coordinator: GLAXOSMITHKLINE BIOLOGICALS, Rixensart, BE<br>Funding: 169800.00<br>Start Date: 2013-07-01<br>End Date: 2015-06-30 2013-07-20T00:00:00+02:00 2013-07-20T00:00:00+02:00 50.7153 4.53326 95337 System for Immunological Modelling as an Ultimate tool to Link Adjuvant function To Adaptive immune responses Coordinator: GLAXOSMITHKLINE BIOLOGICALS, Rixensart, BE<br>Funding: 220500.00<br>Start Date: 2010-06-02<br>End Date: 2012-06-01 2010-06-02T00:00:00+02:00 2010-06-02T00:00:00+02:00 50.7153 4.53326 78572 Recombinant measles virus as a vector for HIV vaccines Coordinator: GLAXOSMITHKLINE BIOLOGICALS, Rixensart, BE<br>Funding: 5499324.00<br>Start Date: 2006-01-01<br>End Date: 2011-05-31 2006-01-01T00:00:00+01:00 2006-01-01T00:00:00+01:00 50.7153 4.53326 64931 Improvement of a therapeutic adjuvanted protein hiv vaccine by combination with dna immunization in prime-boost regimen (HIVPRIMEBOOSTTHERVAC) Coordinator: GLAXOSMITHKLINE BIOLOGICALS, Rixensart, BE<br>Funding: 1062554.00<br>Start Date: 2002-11-01<br>End Date: 2006-04-30 2002-11-01T00:00:00+01:00 2002-11-01T00:00:00+01:00 50.7153 4.53326 51489 A new vaccine strategy against serogroup b meningococcal infection: from antigen discovery to clinical trials Coordinator: GLAXOSMITHKLINE BIOLOGICALS, Rixensart, BE<br>Funding: 2640000.00<br>Start Date: 2000-02-01<br>End Date: 2003-04-01 2000-02-01T00:00:00+01:00 2000-02-01T00:00:00+01:00 50.7153 4.53326